COMMUNIQUÉS West-GlobeNewswire
-
Weight Watchers to Increase Access to Comprehensive Weight Loss Options for Patients Nationwide through LillyDirect
04/06/2026 -
MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial
04/06/2026 -
Baba Selected for CMS ACCESS Model Across All Four Clinical Tracks
04/06/2026 -
Akari Therapeutics Releases CEO Corner Reflecting on Evolving ADC Landscape and Akari’s Differentiated PH1 Payload Platform Following ASCO 2026
04/06/2026 -
Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value
04/06/2026 -
Better Blend Brings a New Kind of Fast Casual to Tampa Bay
04/06/2026 -
Longeveron to Present at BIO International Convention 2026
04/06/2026 -
Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion
04/06/2026 -
Emergency Care Arrives in the Heart of Liberty Hill
04/06/2026 -
Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine
04/06/2026 -
Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation
04/06/2026 -
America's Caregiving Dilemma: 90% Burnout, a Gen Z Reckoning, and the AI Lifeline Families Need
04/06/2026 -
Free Brain Health Assessments Available During June
04/06/2026 -
Stipple Bio Enters Multi-Target License Agreement with Lonza to Advance Precision Oncology ADC Therapies
04/06/2026 -
Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years
04/06/2026 -
Press Release: Sanofi launches 2026 global employee stock purchase plan
04/06/2026 -
Communiqué de presse : Sanofi lance son plan mondial 2026 d’actionnariat salarié
04/06/2026 -
WellSpan Health and Philips Announce Landmark Strategic Alliance, Accelerating Innovation and Research Across Central Pennsylvania and Northern Maryland
04/06/2026 -
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
04/06/2026
Pages